药理学（英文版）

图书标准信息

• 作者 罗大力 编
• 出版社 高等教育出版社
• 出版时间 2015-08
• 版次 1
• ISBN 9787040425413
• 定价 36.60元
• 装帧 平装
• 开本 16开
• 纸张 胶版纸
• 页数 273页
• 字数 510千字
• 正文语种 英语
• 丛书 医学教育改革系列教材

【内容简介】

　　《药理学（英文版）》为“医学教育改革系列教材”（英文）之一，包括6篇41章，第一篇绪论介绍药效学的基本原理、药物作用的分子机制和药代动力学，第二至五篇分述作用于周围神经系统、中枢神经系统、泌尿系统、心血管系统、胃肠道、呼吸系统、内分泌系统的药物，第六篇介绍化学疗法。《药理学（英文版）》主要适用于医学本科生双语教学和留学生教学。

【目录】

Unit1IntroductiontoPharmacology
Chapter1Introduction
1.1Introduction
1.2DrugsandPlacebos
1.3FDAandSFDA
1.4BriefHistoryofPharmacology
1.5Health，DiseaseandDrugTreatment
Chapter2GeneralPrinciplesofPharmacodynamics
2.1Introduction
2.2DrugActionandDrugEffect
2.3Dose-effectRelationship
2.4DrugTherapeuticActionandAdverseDrugReaction
2.5FactorsAffectingtheDrugAction
2.6NewDrugDevelopment
Chapter3TheMolecularMechanismsofDrugAction
3.1Introduction
3.2TheMechanismsofDrugAction
3.3ReceptorTheoriesandInteractionsofDrugsandReceptors
Chapter4Pharmacoldnetics
4.1Introduction
4.2DrugTransport
4.3Compliance
4.4InvivoProcessofDrugs
4.5Pharmacokinetics
4.6DrugInteraction

Unit2DrugsAffectingtheFunctionofNeuroeffectors
Chapter5ThePharmacologicalOutlineofAutonomicNervousSystems
5.1Introduction
5.2NeurotransmittersandPharmacology
Chapter6CholinergicAgonists
6.1Introduction
6.2Choliuoceptor-activatingDrugs
Chapter7CholinergicAntagonists..
7.1Introduction
7.2MuscarinicCholinergicBlockingDrugs
Chapter8AdrenergicAgonists
8.1Introduction
8.2AdrenergicReceptorAgonists
Chapter9AdrenergicAntagonists..
9.1Introduction
9.2AdrenergicReceptorAntagonists
Chapter10LocalAnesthetics
10.1Introduction
10.2ClassificationofLocalAnesthetics
10.3DrugsCommonlyUsedinClinics

Unit3DrugsAffectingtheCentralNervousSystem
Chapter11AnxiolyticandHypnoticDrugs
11.1Introduction
11.2DrugsCommonlyUsedintheTreatmentofAnxietyandInsomnia
Chapter12AntipsychoticDrugs
12.1Introduction
12.2AntipsychoticDrugs
12.3AntidepressantsandAntimanics
Chapter13AntiepilepticDrugs
13.1Introduction
13.2MechanismofActionofAntiepilepticDrugs
13.3AntiepilepticDrugs
13.4GeneralPrinciplesforDrugUsage
Chapter14DrugsforTreatmentofParkinson'sDisease
14.1Introduction
14.2DrugsCommonlyUsedforTreatmentofParkinson'sDisease
Chapter15AnalgesicDrugs
15.1Introduction
15.2AnalgesicDrugs（Opioids）：AgonistsofOpioidReceptors
15.3AntagonistsofOpioidReceptors
Chapter16NonsteroidalAnti-inflammatoryDrugs
16.1Introduction
16.2NonsteroidalAnti-inflammatoryDrugs

Unit4DrugsAffectingRenalandCardiovascularFunction
Chapter17DiureticDrugs
17.1Introduction
17.2CommonlyUsedDiuretics
Chapter18CalciumChannelBlockers
18.1Introduction
18.2TheCommonlyUsedCalciumChannelBlockers
Chapter19DrugsforCongestiveHeartFailure
19.1Introduction
19.2DrugsCommonlyUsedintheTreatmentofCongestiveHeartFailure
Chapter20AntihypertensiveAgents
20.1Introduction
20.2DrugsUsedfortheTreatmentofHypertension
Chapter21AntiarrhythmicDrugs
21.1Introduction
21.2AntiarrhythmiaDrugs
Chapter22AntianginalDrugs
22.1Introduction
22.2DrugsCommonlyUsedintheTreatmentofAngina
Chapter23AntihyperlipidemicDrugs
23.1Introduction
23.2DrugsCommonlyUsedintheTreatmentofHyperlipidemia
Chapter24DrugsAffectingHaemostasisandThrombosis
24.1Introduction
24.2CommonlyUsedDrugs
Chapter25AgentsUsedinAnemia
25.1Introduction
25.2DrugsCommonlyUsedintheTreatmentofAnemia

Unit5DrugsAffectingGastrointestinalTract，RespiratoryorEndocrineSystem
Chapter26SteroidHormones
26.1Introduction
26.2SteroidHormones
Chapter27HormonesofThyroidandAnti-thyroidDrugs
27.1Introduction
27.2ThyroidHormones
27.3AntithyroidDrugs
Chapter28InsulinandOralHypoglycemicDrugs
28.1Introduction
28.2DrugsCommonlyUsedintheTreatmentofDiabetesMellitus
Chapter29DrugsAffectingtheRespiratorySystem
29.1Introduction
29.2DrugsCommonlyUsedintheTreatmentofAirwayDiseases
Chapter30DrugsAffectingtheGastrointestinalSystem
30.1Introduction
30.2DrugsUsedtoTreatPepticUlcerDisease
30.3AntiemeticDrugs
30.4Laxatives

Unit6Chemotherapy
Chapter31IntroductiontoAntimicrobialTherapy
31.1Introduction
31.2SelectionofAntimicrobialAgents
31.3TherapywithCombinedAntimicrobialAgents
Chapter32β-LactamAntibiotics
32.1Introduction
32.2Penicillins
32.3CephalosporinsandCephamycins
32.4Other[3-LactamAntibiotics
32.5β-LactamaseInhibitors（ClavulanicAcid，SulbactamandTazobaetam）~
Chapter33Macrolides，Lincomycins，PolymyxinsandVancomycin
33.1Introduction
33.2Macrolides
33.3Lincomycins
33.4Polymyxins
Chapter34Aminoglycosides
34.1Introduction
34.2CommonlyUsedAminoglycosidesClinically
Chapter35TetracyclinesandChloramphenicol
35.1Introduction
35.2Tetracyclines
35.3Chloramphenicol
Chapter36Quinolones
36.1Introduction
36.2CharacteristicsofQuinolonesandCommonlyUsedQuinolones
Chapter37SulfonamidesandOtherSynthesizedAntimicrobialDrugs
37.1Introduction
37.2Sulfonamides
37.3Trimethoprim
37.4OtherSyntheticAntimicrobialDrugs
Chapter38AntifungalDrugsandAntiviralDrugs
38.1Introduction
38.2DrugsUsedtoTreatFungalInfections
38.3AntiviralDrugs
38.4DrugsUsedtoTreatHIVInfection
Chapter39AntituberculosisDrugsandAntileproticDrugs
39.1Introduction
39.2AntituberculosisDrugs
39.3AntileproticDrugs
Chapter40AntiprotozoanDrugs
40.1Introduction
40.2AntimalarialDrugs
40.3Anti-amebicDrugs
Chapter41AnticancerDrugs
41.1Introduction
41.2AntieaneerDrugs
41.3BiologicalResponseModifiers